Brightstar Associates LLC 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Feb 9, 2024
Insider Transaction Report
Form 4
Brightstar Associates LLC
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2024-02-07$0.01/sh+914,001$9,140→ 23,059,708 total - Exercise of In-Money
Warrants (right to buy)
2024-02-07−914,001→ 48,136 totalExercise: $0.01From: 2022-04-28→ Common Stock (914,001 underlying)
Footnotes (1)
- [F1]The warrants have no expiration date.